These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36057370)

  • 1. Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression.
    Chen X; Chen Y; Chen X; Wei P; Lin Y; Wu Z; Lin Z; Kang D; Ding C
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166534. PubMed ID: 36057370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
    Yin Y; Qiu S; Li X; Huang B; Xu Y; Peng Y
    J Neuroinflammation; 2017 Nov; 14(1):220. PubMed ID: 29132376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CEBPB
    Yang Y; Jin X; Xie Y; Ning C; Ai Y; Wei H; Xu X; Ge X; Yi T; Huang Q; Yang X; Jiang T; Wang X; Piao Y; Jin X
    Theranostics; 2024; 14(10):4107-4126. PubMed ID: 38994023
    [No Abstract]   [Full Text] [Related]  

  • 4. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
    Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
    J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype.
    Stazi G; Taglieri L; Nicolai A; Romanelli A; Fioravanti R; Morrone S; Sabatino M; Ragno R; Taurone S; Nebbioso M; Carletti R; Artico M; Valente S; Scarpa S; Mai A
    Clin Epigenetics; 2019 Dec; 11(1):173. PubMed ID: 31791385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
    Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
    Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability.
    Zhai X; Li LS; Zhou YD; Ji WY; Chen H; Xiao H; Liang P
    Eur J Pharmacol; 2021 Aug; 904():174177. PubMed ID: 34015321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
    Cheng T; Xu Y
    Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CCL2 by EZH2 affects tumor-associated macrophages polarization and infiltration in breast cancer.
    Wang YF; Yu L; Hu ZL; Fang YF; Shen YY; Song MF; Chen Y
    Cell Death Dis; 2022 Aug; 13(8):748. PubMed ID: 36038549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
    Luo W; Li X; Song Z; Zhu X; Zhao S
    Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization.
    Gao C; Nie Y
    Metab Brain Dis; 2024 Apr; 39(4):569-576. PubMed ID: 38300392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.
    Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A
    Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BACH1 as a potential target for immunotherapy in glioblastomas.
    Yuan F; Cong Z; Cai X; Zhu J; Yuan L; Wang Y; Tang C; Ma C
    Int Immunopharmacol; 2022 Feb; 103():108451. PubMed ID: 34923423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2 is a potential prognostic predictor of glioma.
    Chen YN; Hou SQ; Jiang R; Sun JL; Cheng CD; Qian ZR
    J Cell Mol Med; 2021 Jan; 25(2):925-936. PubMed ID: 33277782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
    Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q
    Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.